The Reverend Dr. LaKeesha Walrond Joins Board of Directors of Foundation for Opioid Response Efforts (FORE)
September 22, 2021 11:16 ET
|
Foundation for Opioid Response Efforts
New York, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced that The Reverend Dr. LaKeesha Walrond, President of the New York Theological Seminary...
First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
September 07, 2021 08:30 ET
|
University of Minnesota Medical School
MINNEAPOLIS/ST. PAUL, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use...
CDC Updates List of Health Conditions that Can Increase the Risk of Severe Illness from COVID-19 to include Substance Use Disorders
May 10, 2021 15:41 ET
|
Foundation for Opioid Response Efforts and Addiction Policy Forum
New York & Bethesda, May 10, 2021 (GLOBE NEWSWIRE) -- Health officials have released an update that individuals with substance use disorders (SUD) are at a heightened risk for serious...
Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain
September 28, 2020 09:00 ET
|
Sorrento Therapeutics, Inc.
Phase 1b safety data at 6 month post-administration and Day 84 efficacy data available for all patients enrolled.No dose limiting toxicities at any of the doses tested (up to 30 ug) at 6 months...
PhytoSciences Consultants GmbH Announced West African Expansion with Launch of PhytoSciences Ghana Consultants Limited in an Ongoing Effort to Support Legalizing Medical Cannabis
September 22, 2020 03:00 ET
|
PhytoSciences Consultants Ghana Limited
ACCRA, Ghana, Sept. 22, 2020 (GLOBE NEWSWIRE) -- PhytoSciences Consultants GmbH, an international consulting firm, announced the expansion of its services to West Africa, providing regulatory,...
UPMC Center for High-Value Health Care Awarded $1 Million to Support Substance Use Disorder Care in Bedford and Somerset Counties
September 21, 2020 10:42 ET
|
UPMC Health Plan
PITTSBURGH, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The UPMC Center for High-Value Health Care (Center), a nonprofit research organization housed within UPMC Health Plan, was awarded $1 million from the...
Aegis Sciences Corporation Announces National Launch of Expanded Novel Psychoactive Substance Testing
July 27, 2020 12:10 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
Premera Blue Cross offers zero cost share virtual mental health and substance use disorder treatment during COVID-19 pandemic
April 21, 2020 15:02 ET
|
Premera Blue Cross
Mountlake Terrace, Wash., April 21, 2020 (GLOBE NEWSWIRE) -- Premera Blue Cross, a leading health plan in the Pacific Northwest, today announced an expansion of its zero cost share options for...
athenahealth Hosts Boston Medical Center for Interview Exploring How Data and Insights Will Play a Critical Role in Helping to Reduce Opioid Deaths in the Future
February 24, 2020 09:00 ET
|
athenahealth, Inc.
WATERTOWN, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services for ambulatory and enterprise customers nationwide, has released a new video...
SPR Therapeutics Announces 1000th Sprint PNS Procedure
December 04, 2019 08:30 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...